Since commencing operations in 2012, Cherish Women’s Cancer Foundation has funded several clinical trials and research programs developed by Australian researchers through the Queensland Centre for Gynaecological Cancer Research (QCGC Research) to find kinder ways to treat women with gynaecological cancer.
Here’s how this work will make a difference to the lives of women today and in the future.
feMMe – Improving the treatment for women with early stage cancer of the uterus
Cherish supports flagship Australian research projects like the feMMe Trial that aims to treat obese women with early-stage endometrial cancer less-invasively with the use of an intra-uterine device combined with a weight-loss program and a diabetes drug. If successful, the benefits to patients will include less hospital bed days, less radical surgery, fewer complications and lower costs to patients. Importantly, it will also allow more women to retain their fertility.
IMAGE – improving clinical management world-wide
QCGC Research’s Image trial is the first study in Australia that directly compares CT (Computed Tomography) with PET-CT (Positron Emission Tomography) scanning to determine the most effective medical imaging tool for patients with ovarian cancer outside the abdomen. The outcome could potentially change clinical management of patients with advanced ovarian cancer world-wide. The project has completed enrolment of 84 patients and entering its final phase so that data can be analysed and findings disseminated around the world. Cherish is proud to support internationally significant projects like the IMAGE trial.
LACE – Less invasive surgery recommended for hysterectomies
The LACE trial has had a significant impact on how gynaecological surgery is performed in Australia and world-wide. The Laparoscopic Approach to Carcinoma of the Endometrium (LACE) trial examined the treatment of endometrial cancer (EC) via a laparoscopic (key-hole) hysterectomy vs the traditional, open-abdominal approach.
LACE involved 760 patients, and 27 gynaecological cancer surgeons from 21 cancer centres throughout Australia and New Zealand over 15 years. It showed that women with endometrial cancer who undergo a laparoscopic hysterectomy have, an equivalent overall and disease-free survival rate compared to women receiving an abdominal hysterectomy.
If you would like to make a donation to continue the work of projects like IMAGE, feMMe and LACE, please click here.